1. Ethiopian Public Health Institute (EPHI) and Ministry of Health (MOH). Report on National TB/HIV Sentinel Surveillance, December 2015, Addis Ababa.
2. Federal ministry of health Ethiopia: Implementation guideline for TB/HIV collaborative activities, ministry of health, 2014, Addis Ababa.
3. Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human Syndemic. Clin Microbial Rev 2011; 24:351–76
4. International federations of Red Cross and Red Crescent Societies: The link between tuberculosis and HIV.htt://www.ifrc.org/en/what-we-do/health/disease/tuberculosis/the-link-between-tuberculosis-and-hiv/.Accessed at December 20, 2016.
5. Pawlowski A, Jansson M, Sköld M. Tuberculosis and HIV Co-Infection, Current Trends, Diagnosis and Treatment Update. PLoS Pathog 2012; 8:e1002464.
6. GM Varghese1, J Janardhanan, OC Abrahan: The twin epidemics of tuberculosis and HIV co-infection. Curr Infect Dis Rep. 2013 Feb; 15(1):77-84.
7. Getahun H, Gunneberg C, Granich R, Nunn P. HIV infection-associated tuberculosis: the epidemiology and the response (2010) Clin Infect Dis 50 Suppl 3: S201-207.
8. World health organizations: global tuberculosis report WHO, 2015.
9. World health organizations: global tuberculosis report WHO, 2016.
10. World health organizations: the global plan to end TB 2016-2020
11. Kibret KT, Yalew AW, Belaineh BG, Asres MM. Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case control study. PLoS ONE 2013; 8:e64488.
12. Lonnroth K, Jaramillo E, Williams BG, DyeC, Raviglione M: Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009;68(12):2240-2246.
13. Yim JJ, Selvaraj P: Genetic susceptibility in tuberculosis. Respirology, 2010; 15(2):241-256.
14. Alemu YM, Awoke W, Wilder-Smith A: Determinants for tuberculosis in HIV-infected adults in Northwest Ethiopia: a multicentre case-control study BMJ Open 2016 6(4): e009058
15. Bucher HC, Griffith LE, Guyatt GH. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials (1999). Aids 13: 501-507.
16. Dowdy DW, Golub JE, Saraceni V. Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model (2014). J Acqui Immune Defic Syndr (1999) 66: 552.
17. Deribe KE, Yami AL, Deribew AM. Predictors of Mortality among Tuberculosis-HIV-Co infected Persons in Southwest Ethiopia: A Case–Control Study ,2015 ,J Int Assoc Provid AIDS Care. 2015 May ; 14(3): 269–273.
18. Dalbo M, Tamiso A. Incidence and Predictors of Tuberculosis among HIV/AIDS Infected Patients: A Five-Year Retrospective Follow-Up Study. Advances in Infectious Diseases, 2016, 6, 70-81.
19. M Mugusi F, Mehta S, Villamor E. Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis .BMC Public Health 2009, 9:409.
20. Molaeipoor L, Poorolajal J, MohrazM, EsmailnasabN. Predictors of tuberculosis and human immunodeficiency virus co-infection: a case-control study : epiH 2014:36,(6) ID: e2014024.
21. J. Del Amo J. A.N Petruckevitch. N.Desmond S. Risk factors for tuberculosis in patients with AIDS in London:a case-control study. INT J TUBERC LUNG DIS 1998, 3(1):1217.
22. Matias de CarvalhoBR, Monteiro AJ. Factors Related to HIV/Tuberculosis Co infection in a Brazilian Reference Hospital. J Braz Infec Disea 2008;12(4):281-286.
23. Hiregoudar V, Raghavendra B, Karinagannavar A, Karingannavar A. Proportion and
determinants of tuberculosis among human immunodeficiency virus-positive patients attending the antiretroviral therapy center attached to a Medical College in South India. J Fam Community Med 2016; 23:88-93.
24. Jurcev-Savicevic. Risk factors for pulmonary tuberculosis in Croatia: A matched case–control study. BMC Public Health, 2013, 13:991.
25. Khazaei SA, Molaeipoor LE, Rezaeian SH. Predictors of Tuberculosis in HIV/AIDS Patients Referred to Behavioral Diseases Consultation Center: A Registry-Based Study in Abadan, Southwest of Iran. Shiraz E-Med J. 2016; 17(10):e41542.
26. Lienhardt C FieldingK, Sillah JS, Bah B. Investigation of the risk factors for
tuberculosis: a case–control study in three countries in West Africa. International Journal of Epidemiology 2005; 34:914–9235.
27. C Hill PH, Jackson-Sillah DO, A Donkor SI Donkor SA. Risk factors for pulmonary tuberculosis: a clinic-based case control study in The Gambia. BMC Public Health 2006, 6:156.
28. Herrera Rodriguez FA & Samuel Onoja Agbo SA. An assessment of the risk factors for pulmonary tuberculosis among adult patients suffering from human immunodeficiency virus attending the Wellness Clinic at Themba Hospital, SouthAfrican Family Practice,2015; 57:2, 106-111.
29. Komati ST, A. Shaw PA, Stubbs NO, Mahtomedi MO. Tuberculosis Risk Factors and Mortality for HIV Infected Persons Receiving Antiretroviral Therapy in South Africa. AIDS. 2010; 24(12): 1849–1855.
30. Hermans SM, Kiragga AN, Schaefer P. Incident Tuberculosis during Antiretroviral Therapy Contributes to Suboptimal Immune Reconstitution in a Large Urban HIV Clinic in Sub-Saharan Africa. PLoS ONE 2010; 5(5): e10527.
31. Agbaji O, Ebonyi AO, Meloni ST, Anejo-Okopi JA, Akanbi MO. Factors associated With Pulmonary Tuberculosis-HIV Co-Infection in Treatment-Naive Adults in Jos, North Central Nigeria. J AIDS Clin Res 2013; 4: 222.
32. LIU E, MAKUBI A, Paul DRAIN Pl. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy in Tanzania. AIDS. 2015; 29(11): 1391–1399.
33. A.Heitham, El-S.Fateh, A. S.Mohammed, and M.Mahgoub. Risk Factors Associated with the Development of Tuberculosis Among HIV-Infected Patients in Khartoum in. AIMS Public Health 2010, 2 (4): 784-792.
34. Dalbo, M. and Tamiso A. Incidence and Predictors of Tuberculosis among HIV/AIDS Infected Patients: A Five-Year Retrospective Follow-Up Study. Advances in Infectious Diseases, (2016) 6, 70-81.
35. Taha M, Deribew A, Tessema F, Assegid S. risk factors of active tuberculosis in people living with HIV/AIDS in southwest Ethiopia: a case-control study Ethiop J Health Sci-2011,21(2):131-139.
36. Melkamu H, Seyoum B, Dessie Y .Determinants of Tuberculosis Infection among Adult HIV Positives Attending Clinical Care in Western Ethiopia: A Case-Control Study. AIDS Rese and Treat (2013) 1-7.
37. Fekadu S, Teshome W, Alemu G. Prevalence and determinants of Tuberculosis among HIV infected patients in south Ethiopia .J Infect Dev Ctries 2015; 9(8):898-904.
38. Seada Mohammed S, Gebremariam T. Tuberculosis among HIV-positive patients at Butajira Hospital, South-Central Ethiopia. (IJPSR), 2015; 6(12):1409-1410.
39. Mitku AA, Dessie ZG, Muluneh EK, Workie DL. Prevalence and associated factors of TB/HIV co-infection among HIV Infected patients in Amhara region, Ethiopia. Afri Health Sci 2016;16(2): 588-595.
40. Mekonnen D ,Derbie A, Desalegn E . TB/HIV co‑infections and associated factors among patients on directly observed treatment short course in Northeastern Ethiopia: a 4 years retrospective study. BMC Res Notes (2015) 8:666.
41. Belay A, Alamrew Z, Berie Y,Tegegne B, Tiruneh G, Feleke A. Magnitude and Correlates of Tuberculosis among HIV Patients at Felege Hiwot Referral Hospital, Bahir Dar City, Northwest Ethiopia. Clinical Medicine Research. Vol. 2, No. 4, 2013, pp. 77-83.
42. Alvi A, Rizwan M, Sunosi RA. Does khat chewing increases the risk of Mycobacterium tuberculosis infection by macrophage immune modulation? Med Hypotheses 2014; 82:667–9.
43. Esmael A, Tsegaye G, Wubie M, Endris M .Tuberculosis and Human Immune Deficiency Virus Co-infection in Debre Markos Referral Hospital in Northwest Ethiopia: A Five Years Retrospective Study. J AIDS Clin Res 2013; 4: 263.